Kimberly LovettRockwell M.D.

Dr. Kimberly Lovett Rockwell's experience as a board certified physician informs her approach to providing health care legal, regulatory, and compliance counsel to health care and non-health care entities. Throughout the COVID-19 (coronavirus) public health crisis, she has advised large corporate clients on policies and procedures for temperature screening, face covering, COVID-19 testing, and return-to-work protocols. She has also advised health care clients looking to expand telehealth programming in response to the COVID-19 crisis.

Kimberly advises clients on a range of state and federal legal and regulatory issues, including health care fraud, waste, and abuse laws and investigations arising under the False Claims Act (FCA), the Anti-Kickback Statute (AKS), civil monetary penalties, and fee-splitting laws; U.S. Food and Drug Administration (FDA) regulations; compliance program organization and implementation; telehealth and digital health practice structuring, restrictions, and reimbursement; supervision of non-physician providers; and corporate practice of medicine prohibitions.

Kimberly has held academic appointments at Stanford University and the University of California, San Diego and has given lectures on myriad health policy issues, including telehealth reform, health care reform, Medicare reform, and quality measurement. She has published book chapters and articles in peer-reviewed journals, including the Journal of the American Medical Association and Nature Reviews Cancer. Kimberly has served on the board of directors for the Michigan State Medical Society and the San Diego County Medical Society and also has served on numerous committees for the California Medical Association. She is a long-standing member of the American Medical Association and continues to serve primary care patients.